ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Washington » Internal Medicine

Top Internal Medicine Prescribers in Washington

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
LARRY MCKNIGHT M.D.

Internal Medicine

813

$41.9K

189
155 are 65+

16%
patients receiving schedule two controlled substances

Avg: 7%

19%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 23%

$52
Average prescription price

Avg: $56

MELISSA MOLSEE MD

Internal Medicine

812

$30.5K

106
83 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 23%

$38
Average prescription price

Avg: $56

MELDY TASWIN MD

Internal Medicine

796

$35.9K

148
132 are 65+

10%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 10%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 23%

$45
Average prescription price

Avg: $56

ETHAN BABCOCK M.D.

Internal Medicine

794

$37.5K

41
16 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 23%

$47
Average prescription price

Avg: $56

HARRY KNASTER M.D.

Internal Medicine

769

$28.2K

102
59 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

14%
prescriptions for brand name drugs

Avg: 23%

$37
Average prescription price

Avg: $56

CHRISTOPHER BEHNE D.O.

Internal Medicine

768

$42K

67
32 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

19%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 23%

$55
Average prescription price

Avg: $56

OLIVIER DROUIN M.D.

Internal Medicine

761

$51K

103
47 are 65+

24%
patients receiving schedule two controlled substances

Avg: 7%

38%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 23%

$67
Average prescription price

Avg: $56

RUBY JEAN TOE HIO M.D.

Internal Medicine

758

$33.7K

191
168 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

9%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 23%

$44
Average prescription price

Avg: $56

CHETAN PUNGOTI M.D.

Internal Medicine

754

$32.9K

122
110 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 23%

$44
Average prescription price

Avg: $56

ADEENA KHAN M.D.

Internal Medicine

739

$25.7K

25
11 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 23%

$35
Average prescription price

Avg: $56

ARUN KALYANASUNDARAM M.D.

Internal Medicine

712

$54.8K

88
75 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 23%

$77
Average prescription price

Avg: $56

TARIQ GILL M.D.

Internal Medicine

671

$109K

102
93 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 23%

$163
Average prescription price

Avg: $56

MATTHEW FEI MD

Internal Medicine

665

$109K

132
113 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

65%
prescriptions for brand name drugs

Avg: 23%

$164
Average prescription price

Avg: $56

ERIC FELDMAN M.D.

Internal Medicine

662

$377K

117
103 are 65+

16%
patients receiving schedule two controlled substances

Avg: 7%

12%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 23%

$570
Average prescription price

Avg: $56

CAROL WORKMAN MD

Internal Medicine

652

$40.6K

27
20 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 23%

$62
Average prescription price

Avg: $56

MATTHEW HOLLON MD, MPH

Internal Medicine

652

$25K

36
18 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

12%
prescriptions for brand name drugs

Avg: 23%

$38
Average prescription price

Avg: $56

KATE CAVENY M.D.

Internal Medicine

644

$36.4K

87
45 are 65+

17%
patients receiving schedule two controlled substances

Avg: 7%

28%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

13%
prescriptions for brand name drugs

Avg: 23%

$57
Average prescription price

Avg: $56

CRISTOBAL SANCHEZ METZ MD

Internal Medicine

639

$32.4K

146
82 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 23%

$51
Average prescription price

Avg: $56

JOCELYN JAMES MD

Internal Medicine

637

$23.8K

33
12 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 23%

$37
Average prescription price

Avg: $56

DEBORAH MEYERS MD

Internal Medicine

587

$66.7K

86
61 are 65+

53%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 10%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 23%

$114
Average prescription price

Avg: $56

ELIZABETH POTTER MD

Internal Medicine

582

$24.9K

42
23 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

15%
prescriptions for brand name drugs

Avg: 23%

$43
Average prescription price

Avg: $56

MAGGIE SEKERAMAYI MD

Internal Medicine

578

$40.8K

191
139 are 65+

14%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 23%

$71
Average prescription price

Avg: $56

DONALD LITEANU M.D.

Internal Medicine

578

$38.3K

99
26 are 65+

12%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

16%
prescriptions for brand name drugs

Avg: 23%

$66
Average prescription price

Avg: $56

JILL ENRIGHT M.D.

Internal Medicine

566

$32.3K

107
100 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 23%

$57
Average prescription price

Avg: $56

JEFFREY JONES M.D.

Internal Medicine

559

$150K

193
154 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 23%

$268
Average prescription price

Avg: $56

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank